Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.

Berasain C, Ujue Latasa M, Urtasun R, Goñi S, Elizalde M, Garcia-Irigoyen O, Azcona M, Prieto J, Avila MA.

Cancers (Basel). 2011 May 18;3(2):2444-61. doi: 10.3390/cancers3022444.

2.

Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.

Berasain C, Goñi S, Castillo J, Latasa MU, Prieto J, Avila MA.

World J Gastroenterol. 2010 Jul 7;16(25):3091-102. Review.

3.

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.

Pardo-Saganta A, Latasa MU, Castillo J, Alvarez-Asiain L, Perugorría MJ, Sarobe P, Rodriguez-Ortigosa CM, Prieto J, Berasain C, Santamaría M, Avila MA.

J Hepatol. 2009 Dec;51(6):1010-20. doi: 10.1016/j.jhep.2009.06.030. Epub 2009 Sep 12.

4.

Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors.

Castillo J, Goñi S, Latasa MU, Perugorría MJ, Calvo A, Muntané J, Bioulac-Sage P, Balabaud C, Prieto J, Avila MA, Berasain C.

Gastroenterology. 2009 Nov;137(5):1805-15.e1-4. doi: 10.1053/j.gastro.2009.07.065. Epub 2009 Aug 5.

PMID:
19664633
5.

The epidermal growth factor receptor: a link between inflammation and liver cancer.

Berasain C, Perugorria MJ, Latasa MU, Castillo J, Goñi S, Santamaría M, Prieto J, Avila MA.

Exp Biol Med (Maywood). 2009 Jul;234(7):713-25. doi: 10.3181/0901-MR-12. Epub 2009 May 8. Review.

PMID:
19429859

Supplemental Content

Loading ...
Support Center